{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:04:55Z","timestamp":1789643095937,"version":"4.0.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaad.2026.03.129","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:58:44Z","timestamp":1781312324000},"page":"e383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interpreting outcomes after switching oral Janus kinase inhibitors in alopecia areata: Comment on \u201cSwitching between Janus kinase inhibitors for treatment of alopecia areata: A multi-center retrospective review\u201d"],"prefix":"10.1016","volume":"95","author":[{"given":"Ke","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.03.129_bib1","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.jaad.2026.01.055","article-title":"Switching between Janus kinase inhibitors for treatment of alopecia areata: a multicenter retrospective review","volume":"94","author":"Martin","year":"2026","journal-title":"J Am Acad Dermatol"},{"issue":"18","key":"10.1016\/j.jaad.2026.03.129_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two phase 3 trials of baricitinib for alopecia areata","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"issue":"10387","key":"10.1016\/j.jaad.2026.03.129_bib3","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(23)00222-2","article-title":"Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomized, double-blind, multicenter, phase 2b-3 trial","volume":"401","author":"King","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jaad.2026.03.129_bib4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jaad.2023.03.041","article-title":"Switching between tofacitinib and baricitinib in alopecia areata: a review of clinical response","volume":"89","author":"Kazmi","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.03.129_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00403-025-04035-y","article-title":"Switching JAK inhibitors: evaluating baricitinib's effectiveness in alopecia areata after tofacitinib failure","volume":"317","author":"Ehsani","year":"2025","journal-title":"Arch Dermatol Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226028902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226028902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:57:46Z","timestamp":1789642666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226028902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0190962226028902"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.03.129","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interpreting outcomes after switching oral Janus kinase inhibitors in alopecia areata: Comment on \u201cSwitching between Janus kinase inhibitors for treatment of alopecia areata: A multi-center retrospective review\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.03.129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.06.035","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}